Cargando…

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis

Detalles Bibliográficos
Autores principales:	Liao, Shu-Yi, Gerber, Anthony N., Zelarney, Pearlanne, Make, Barry, Wechsler, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Chest Infections: Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743857/ https://www.ncbi.nlm.nih.gov/pubmed/35016912 http://dx.doi.org/10.1016/j.chest.2021.12.654

Ejemplares similares

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis
por: Liao, Shu-Yi, et al.
Publicado: (2022)

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
por: Liu, Haolin, et al.
Publicado: (2023)

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
por: Liu, Haolin, et al.
Publicado: (2023)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

INFECTIOUS COMPLICATIONS AFTER TOCILIZUMAB IN PATIENTS WITH COVID: A REAL-WORLD EXPERIENCE
por: LIU, HONGLI, et al.
Publicado: (2022)

THE IMPACT OF COVID-19 VACCINATION ON DISEASE SEVERITY AND OUTCOMES IN HOSPITALIZED PATIENTS: A REAL-WORLD EXPERIENCE
por: SATISH, V., et al.
Publicado: (2022)

CLINICAL CONDITION AND SYMPTOMS OF PATIENTS WITH ASTHMA AND SARS-COV-2 INFECTION IN COLOMBIA
por: BETANCOURT-PEÑA, J., et al.
Publicado: (2022)

A CASE OF PROLONGED SARS-COV-2 INFECTION IN AN IMMUNOSUPPRESSED PATIENT WHO RESPONDED TO TREATMENT WITH REMDESIVIR AND MONOCLONAL ANTIBODIES
por: SINANAN, VIVEK
Publicado: (2022)

MASK UP WORLD...IT’S 100% SAFE
por: PATIL, S.
Publicado: (2022)

A RARE CASE OF INTERNAL JUGULAR VEIN THROMBOSIS AFTER MRNA COVID-19 VACCINE
por: HONG, SUNG, et al.
Publicado: (2021)

COVID-19 CHRONIC IMPAIRMENT WITH PULMONARY SYMPTOMS
por: GOERTZEN, STEPHEN M, et al.
Publicado: (2022)

COVID-19 COAGULOPATHY SECONDARY TO ACTIVATING PLATELET ANTIBODIES
por: KEWAN, TARIQ, et al.
Publicado: (2021)

VACCINE-INDUCED ANTIBODY DEPENDENT ENHANCEMENT IN COVID-19
por: SRIDHAR, PRIYANKA, et al.
Publicado: (2022)

SARS-COV-2 INFECTION WITH RITUXIMAB THERAPY
por: AUGENSTEIN, CHERYL, et al.
Publicado: (2022)

PLEURAL EFFUSIONS DUE TO SARS-COV-2 INFECTION
por: Ayala, Alvaro, et al.
Publicado: (2020)

SARS-COV-2 INFECTION AND HEMOFILTRATION-TARGETING VIREMIA
por: MEECE, LYDIA, et al.
Publicado: (2022)

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients
por: Wynia, Matthew K., et al.
Publicado: (2023)

ROLE OF BRONCHOSCOPY IN THE DIAGNOSIS OF SARS-COV-2: CASE REPORT
por: Lamboy, Ilean, et al.
Publicado: (2020)

PNEUMOTHORAX IN SEVERE ILL PATIENTS ADMITTED DUE TO SARS-COV-2
por: Uribe, Juan Pablo, et al.
Publicado: (2020)

PULMONARY CAVITARY TB IN A PATIENT WITH SARS COV 2 PNEUMONIA
por: Sasson, Arielle, et al.
Publicado: (2020)

SARCOIDOSIS WITH SUPERIMPOSED SARS-COV-2 LEADING TO HIGHER PREVALENCE OF CAPA?
por: JAHIR, TAHMINA, et al.
Publicado: (2021)

MULTISYSTEM INFLAMMATORY SYNDROME IN AN ADULT POST-SARS-COV-2 INFECTION
por: CHUG, LUIS, et al.
Publicado: (2021)

INTERSTITIAL LUNG DISEASE EXACERBATED BY NON-NOVEL SARS-COV-2
por: FAKUNLE, IBUKUN, et al.
Publicado: (2022)

A CASE OF SARS-COV-2 ASSOCIATED WITH QUADRUPLE BACTERIAL COINFECTION
por: JIMENEZ, KATIRIA PINTOR, et al.
Publicado: (2022)

UTILITY OF REVERSE-TRANSCRIPTION POLYMERASE CHAIN REACTION IN SEVERE SARS-COV-2 INFECTION
por: Desai, Viral, et al.
Publicado: (2020)

A REPORT OF FUNGAL EMPYEMA FOLLOWING RECOVERY OF SEVERE SARS-COV-2 INFECTION
por: Glendening, Joseph, et al.
Publicado: (2020)

ARDS IN CYSTIC FIBROSIS PATIENT WITH DOUBLE LUNG TRANSPLANT SURVIVES SARS-COV-2
por: Modugula, Sujith, et al.
Publicado: (2020)

THE RELATIONSHIP BETWEEN SERUM ACE LEVEL AND HYPERTENSION DRUGS IN PATIENTS WITH SARS-COV-2
por: MÜCAHIT ÜNAL, ALI, et al.
Publicado: (2021)

COLCHICINE TREATMENT IN SARS-COV-2 INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: BERAN BERAN, AZIZULLAH, et al.
Publicado: (2021)

AN UNEXPECTED RECURRENCE: A CASE OF PNEUMOCYSTIS JIROVECI AND SARS-COV-2 IN AN IMMUNOCOMPROMISED PATIENT
por: PALACIOS, CARLOS, et al.
Publicado: (2022)

RETROSPECTIVE ANALYSIS OF PULMONARY FUNCTION DURING THE POSTACUTE SEQUELAE OF SARS-COV-2 INFECTION
por: DIPOLLINA, CHRISTOPHER, et al.
Publicado: (2022)

HERPES SIMPLEX VIRUS PNEUMONITIS IN A CRITICALLY ILL PATIENT WITH SARS-COV-2
por: HASSAN, SYEDA F, et al.
Publicado: (2022)

TO TEST OR NOT TO TEST? A CASE OF SARS-COV-2 AND INFLUENZA A VIRUS CO-INFECTION
por: Van Mecl, Amanda, et al.
Publicado: (2020)

TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
por: AHMED, MUBASHIR AYAZ, et al.
Publicado: (2022)

PULMONARY INFECTIONS IN PATIENTS RECEIVING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR SARS-COV2-RELATED ARDS
por: HALANI, VARUN, et al.
Publicado: (2022)

COVID-19 VARIANTS AMONG US? PATIENT WITH COVID-19 CLINICAL PHENOTYPE, NEGATIVE RT-PCR TESTING, BUT POSITIVE IGM ANTIBODIES
por: REDDY, RENUKA, et al.
Publicado: (2021)

BASELINE CHARACTERISTICS AND MORTALITY IN PATIENTS WITH SARS-COV-2 CONFIRMED INFECTION: SINGLE MAJOR ACADEMIC CENTER EXPERIENCE
por: Uribe, Juan Pablo, et al.
Publicado: (2020)

COMPUTERIZED TOMOGRAPHY OF CHEST AND ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR OF POSITIVE SARS-COV-2 POLYMERASE CHAIN REACTION
por: SCHANZ, OLIVIA, et al.
Publicado: (2021)

ADVANCED LUNG CANCER INFLAMMATORY INDEX AS A PROGNOSTIC MARKER FOR OXYGEN REQUIREMENT IN PATIENTS ADMITTED WITH SARS-COV-2 INFECTION
por: SRIDHAR, ARTHI, et al.
Publicado: (2021)

A FOUR-BODING FUTURE: POLYVIRAL INFECTION WITH SARS-COV-2, PARAINFLUENZA VIRUS TYPE 3, INFLUENZA A, AND ADENOVIRUS
por: KUSUPATI, VINITA, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3a1541ehd2u5l5fpi37e69iend